Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N R Cutler

Showing results (21-30 of 166) with videos related to

Pageof 17
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 27, 2001
Review of the next generation of Alzheimer's disease therapeutics: challenges for drug developmentN R Cutler, J J Sramek
Alzheimer Disease and Associated Disorders|January 1, 1995
The target population in phase I clinical trials of cholinergic compounds in Alzheimer disease: the role of the "bridging study"N R Cutler, J J Sramek
Experimental Aging Research|January 1, 1983
Assessing the noradrenergic system in normal aging: a review of methodologyN R Cutler, J E Hodes
Comprehensive Psychiatry|January 1, 1979
The effect of one night's sleep loss on mood and memory in normal subjectsN R Cutler, H B Cohen
The American Journal of Psychiatry|November 1, 1977
Proven asymptomatic eosinophilia with imipramineN R Cutler, D J Anderson
Journal of Clinical Pharmacology|November 15, 2000
Investigator perspective on MTD: practical application of an MTD definition--has it accelerated development?N R Cutler, J J Sramek
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|December 9, 2000
Women's health care during the perimenopauseE J Frackiewicz, N R Cutler
Alzheimer Disease and Associated Disorders|July 3, 1998
Guidelines for conducting bridging studies in Alzheimer diseaseN R Cutler, J J Sramek
The American Journal of Psychiatry|January 1, 1978
Who was first?N R Cutler, D J Anderson
European Journal of Clinical Pharmacology|January 1, 1995
Scientific and ethical concerns in clinical trials in Alzheimer's patients: the bridging studyN R Cutler, J J Sramek
Pageof 17

Showing results (21-30 of 166) with videos related to

Sort By:
Pageof 17
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 27, 2001
Review of the next generation of Alzheimer's disease therapeutics: challenges for drug developmentN R Cutler, J J Sramek
Alzheimer Disease and Associated Disorders|January 1, 1995
The target population in phase I clinical trials of cholinergic compounds in Alzheimer disease: the role of the "bridging study"N R Cutler, J J Sramek
Experimental Aging Research|January 1, 1983
Assessing the noradrenergic system in normal aging: a review of methodologyN R Cutler, J E Hodes
Comprehensive Psychiatry|January 1, 1979
The effect of one night's sleep loss on mood and memory in normal subjectsN R Cutler, H B Cohen
The American Journal of Psychiatry|November 1, 1977
Proven asymptomatic eosinophilia with imipramineN R Cutler, D J Anderson
Journal of Clinical Pharmacology|November 15, 2000
Investigator perspective on MTD: practical application of an MTD definition--has it accelerated development?N R Cutler, J J Sramek
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|December 9, 2000
Women's health care during the perimenopauseE J Frackiewicz, N R Cutler
Alzheimer Disease and Associated Disorders|July 3, 1998
Guidelines for conducting bridging studies in Alzheimer diseaseN R Cutler, J J Sramek
The American Journal of Psychiatry|January 1, 1978
Who was first?N R Cutler, D J Anderson
European Journal of Clinical Pharmacology|January 1, 1995
Scientific and ethical concerns in clinical trials in Alzheimer's patients: the bridging studyN R Cutler, J J Sramek
Pageof 17